From pipeline to patient: new developments in cystic fibrosis therapeutics

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.3, 2013-02, pp. : 323-329

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment strategies for cystic fibrosis: what's in the pipeline?

By Frerichs Carley Smyth Alan

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 7, 2009-05 ,pp. : 1191-1202

Informa Healthcare

Access to resources Recommend Favorite

New drugs for cystic fibrosis

By Wilschanski Michael Kerem Eitan

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 9, 2011-09 ,pp. : 1285-1292

Informa Healthcare

Access to resources Recommend Favorite

New Therapies in Cystic Fibrosis

Current Pharmaceutical Design, Vol. 18, Iss. 5, 2012-02 ,pp. : 614-627

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: New Developments in Pharmaceutical Treatments for Cystic Fibrosis (Executive Guest Editor: Hartmut Grasemann)]

Current Pharmaceutical Design, Vol. 18, Iss. 5, 2012-02 ,pp. : 613-613

Bentham Science Publishers

Access to resources Recommend Favorite

New Antimicrobial Strategies in Cystic Fibrosis

By >

Pediatric Drugs, Vol. 12, Iss. 6, 2010-12 ,pp. : 343-352

Adis International

Access to resources Recommend Favorite